IMC Chicago LLC Has $259,000 Stock Holdings in Direxion Daily S&P Biotech Bull 3x Shares $LABU

IMC Chicago LLC trimmed its holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) by 89.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,558 shares of the company’s stock after selling 13,087 shares during the period. IMC Chicago LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $259,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in LABU. Qube Research & Technologies Ltd bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the second quarter worth about $26,000. Squarepoint Ops LLC boosted its stake in Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares during the last quarter. Headlands Technologies LLC acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter valued at about $69,000. JPMorgan Chase & Co. acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at about $3,208,000. Finally, Group One Trading LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $349,000.

Direxion Daily S&P Biotech Bull 3x Shares Price Performance

Shares of Direxion Daily S&P Biotech Bull 3x Shares stock opened at $254.80 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 52 week low of $58.35 and a 52 week high of $333.00. The business has a 50 day moving average price of $218.82 and a 200-day moving average price of $187.08.

About Direxion Daily S&P Biotech Bull 3x Shares

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.